Matthew O’Connor
Duke University(US)Dumfries and Galloway Royal Infirmary(GB)Auckland City Hospital(NZ)
Publications by Year
Research Areas
Cardiac pacing and defibrillation studies, Cardiac Arrhythmias and Treatments, Lung Cancer Treatments and Mutations, Cardiac electrophysiology and arrhythmias, Congenital Heart Disease Studies
Most-Cited Works
- → Discovery of OSI-906: A Selective and Orally Efficacious Dual Inhibitor of the IGF-1 Receptor and Insulin Receptor(2009)307 cited
- → A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor–dependent tumor growth in vivo(2007)147 cited
- → OSI-930: A Novel Selective Inhibitor of Kit and Kinase Insert Domain Receptor Tyrosine Kinases with Antitumor Activity in Mouse Xenograft Models(2006)80 cited
- → Optimizing Cerebral Autoregulation May Decrease Neonatal Regional Hypoxic-Ischemic Brain Injury(2016)75 cited
- → Inducible expression of TGFβ, Snail and Zeb1 recapitulates EMT in vitro and in vivo in a NSCLC model(2011)59 cited
- → Conduction System Pacing Versus Conventional Cardiac Resynchronization Therapy in Congenital Heart Disease(2022)43 cited